MARKET

SSKN

SSKN

Strata Skin Sciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.130
+0.030
+2.70%
Closed 16:00 05/27 EDT
OPEN
1.170
PREV CLOSE
1.100
HIGH
1.170
LOW
1.090
VOLUME
7.70K
TURNOVER
6.07K
52 WEEK HIGH
1.950
52 WEEK LOW
1.029
MARKET CAP
39.23M
P/E (TTM)
-14.0161
1D
5D
1M
3M
1Y
5Y
STRATA Skin Sciences Names Michael E. Goodman as Head of International Sales
HORSHAM, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced ...
GlobeNewswire · 05/16 20:05
Strata Skin Sciences, Inc. (SSKN) Reports Q1 Loss, Tops Revenue Estimates
Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -40% and 1.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/11 21:55
Strata Skin Sciences Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $7.04M Beat $6.95M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is unchanged from the same period last year. The company
Benzinga · 05/11 20:49
BRIEF-STRATA Skin Sciences Reports First Quarter 2022 Financial Results
reuters.com · 05/11 20:44
Strata Skin Sciences: Q1 Earnings Insights
Strata Skin Sciences (NASDAQ:SSKN) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Benzinga · 05/11 20:43
STRATA Skin Sciences GAAP EPS of -$0.07, revenue of $7M
STRATA Skin Sciences press release (NASDAQ:SSKN): Q1 GAAP EPS of -$0.07. Revenue of $7M (+20.1% Y/Y). FY22 revenue expected to be in the range of $33.0M to $35.0M.
Seekingalpha · 05/11 20:17
-- Earnings Flash (SSKN) STRATA SKIN SCIENCES Posts Q1 Revenue $7M, vs. Street Est of $6.95M
MT Newswires · 05/11 16:16
STRATA Skin Sciences Q1 2022 Earnings Preview
STRATA Skin Sciences (NASDAQ:SSKN) is scheduled to announce Q1 earnings results on Wednesday, May 11th, after market close. The consensus EPS Estimate is -$0.06 and the consensus Revenue Estimate is
Seekingalpha · 05/10 21:35
More
No Data
Learn about the latest financial forecast of SSKN. Analyze the recent business situations of Strata Skin Sciences Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

100.00%Strong Buy
0.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SSKN stock price target is 4.300 with a high estimate of 4.600 and a low estimate of 4.000.
High4.600
Average4.300
Low4.000
Current 1.130
EPS
Actual
Estimate
-0.05-0.03-0.010.02
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 41
Institutional Holdings: 13.79M
% Owned: 39.72%
Shares Outstanding: 34.72M
TypeInstitutionsShares
Increased
6
808.33K
New
4
34.68K
Decreased
5
492.70K
Sold Out
1
57.58K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+3.80%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Non-Executive Chairman/Independent Director
Uri Geiger
President/Chief Executive Officer/Director
Robert Moccia
Chief Financial Officer
Christopher Lesovitz
Independent Director
William Humphries
Independent Director
Samuel Navarro
Independent Director
Samuel Rubinstein
Independent Director
Nachum Shamir
Independent Director
Douglas Strang
Independent Director
Patricia Walker
No Data
No Data
About SSKN
STRATA Skin Sciences, Inc. is a medical technology company. The Company is engaged in plastic surgery, developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company's products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. The Company's XTRAC excimer laser delivers a targeted therapeutic beam of ultraviolet B (UVB) light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma. Pharos is its excimer laser device that emits concentrated ultraviolet (UV) light and is used as a tool in the treatment of dermatological skin disorders. VTRAC is a UV light lamp system utilized in the treatment of psoriasis, vitiligo and various other skin conditions.

Webull offers kinds of STRATA Skin Sciences Inc stock information, including NASDAQ:SSKN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SSKN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SSKN stock methods without spending real money on the virtual paper trading platform.